Neuronal dysfunction in Down syndrome: Contribution of neuronal models in cell culture

Journal of Physiology Paris

Volumn 99, Issue 2-3, 2006, Pages 201-210

  Saud, Katherine ^a   Arriagada, Christian ^a   Cárdenas, Ana María ^b   Shimahara, Takeshi ^c   Allen, David D ^d   Caviedes, Raúl ^a   Caviedes, Pablo ^a  

^a UNIVERSITY OF CHILE   (Chile)

^b UNIVERSIDAD DE VALPARAÍSO   (Chile)

^c CNRS   (France)

^d TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Cell lines; Down syndrome; Gene dosage; Neuron

Indexed keywords

4 AMINOBUTYRIC ACID; ACETYLCHOLINE; GLUTAMIC ACID;

BRAIN CORTEX; BRAIN ELECTROPHYSIOLOGY; CALCIUM CELL LEVEL; CALCIUM SIGNALING; CELL IMMORTALIZATION; CENTRAL NERVOUS SYSTEM DISEASE; CONFERENCE PAPER; DISEASE MODEL; DOWN SYNDROME; GENE DOSAGE; GENETIC ASSOCIATION; HIPPOCAMPUS; HUMAN; INCIDENCE; MENTAL DEFICIENCY; MOLECULAR GENETICS; NERVE CELL CULTURE; NERVE CELL MEMBRANE POTENTIAL; NEUROPATHOLOGY; NEUROTRANSMISSION; NONHUMAN; SPINAL CORD; SPINAL GANGLION; TRISOMY 16; TRISOMY 21;

ANIMALS; CELL CULTURE TECHNIQUES; DOWN SYNDROME; HUMANS; MODELS, NEUROLOGICAL; NEURONS;

EID: 33645024791     PISSN: 09284257     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jphysparis.2005.12.013     Document Type: Conference Paper

References (131)

1. L.D. Acevedo, Z. Galdzicki, A.R. McIntosh, and S.I. Rapoport Increased inward current in septal neurons from the trisomy 16 mouse, a model for Down's syndrome Brain Res. 701 1995 89 98
2. D.D. Allen, J. Martín, C. Arriagada, A.M. Cárdenas, S.I. Rapoport, R. Caviedes, and P. Caviedes Impaired cholinergic function in cell lines derived from the cerebral cortex of normal and trisomy16 mice Eur. J. Neurosci. 12 2000 3259 3264
3. D.D. Allen, A.M. Cárdenas, C. Arriagada, L.B. Bennett, C.J. García, S.I. Rapoport, R. Caviedes, and P. Caviedes A dorsal root ganglia cell line derived from trisomy 16 fetal mice, a model for Down Syndrome Neuroreport 13 2002 49 496
4. S.E. Antonarakis, R. Lyle, E.T. Dermitzakis, A. Reymond, and S. Deutsch Chromosome 21 and Down syndrome: from genomics to pathophysiology Nat. Rev. Genet. 5 10 2004 725 738
5. Y. Arai, M. Mizuguchi, and S. Takashima Excessive glutamate receptor 1 immunoreactivity in adult Down syndrome brains Pediatr. Neurol. 15 3 1996 203 206
6. N. Arispe, E. Rojas, and H.B. Pollard Giant multilevel cation channels formed by Alzheimer disease amyloid beta-protein [A beta P-(1-40)] in bilayer membranes Proc. Natl. Acad. Sci. USA 90 22 1993 10573 10577
7. 2+- channel hypothesis for neuronal death in Alzheimer disease Mol. Cell Biochem. 140 2 1994 119 125
8. C. Arriagada, A.M. Cárdenas, R. Caviedes, S.I. Rapoport, and P. Caviedes Cells of the neuronal cell line CTb, derived from cerebral cortex of trisomy 16 mouse, accumulate amyloid in intracytoplasmic vacuole-like compartments Soc. Neurosci. Abstr. 2000 180.14
9. B. Ault, P. Caviedes, and S.I. Rapoport Neurophysiological abnormalities in cultured dorsal root ganglion neurons from the trisomy 16 mouse fetus, a model for Down Syndrome Brain Res. 485 1989 165 170
10. B. Ault, P. Caviedes, J. Hidalgo, C.J. Epstein, and S.I. Rapoport Electrophysiological analysis of cultured fetal mouse dorsal root ganglion neurons transgenic for human superoxide dismutase-1, a gene in the obligate Down syndrome region of chromosome 21 Brain Res. 497 1989 191 194
11. E.H. Aylward, Q. Li, N.A. Honeycutt, A.C. Warren, M.B. Pulsifer, P.E. Barta, M.D. Chan, P.D. Smith, M. Jerram, and G.D. Pearlson MRI volumes of the hippocampus and amygdala in adults with Down's syndrome with and without dementia Am. J. Psychiatry 156 1999 564 568
12. N.P. Azari, B. Horwitz, K.D. Pettigrew, C.L. Grady, J.V. Haxby, K.R. Giacometti, and M.B. Schapiro Abnormal pattern of cerebral glucose metabolic rates involving language areas in young adults with Down syndrome Brain Lang. 46 1994 1 20
13. B. Begnia, L. Brighinaa, L. Fumagallia, S. Andreonia, E. Castellib, C. Francesconic, R. Del Bod, N. Bresolind, and C. Ferraresea Altered glutamate uptake in peripheral tissues from Down Syndrome patients Neurosci. Lett. 343 2003 73 76
14. B. Bettler, J. Boulter, I. Hermans-Borgmeyer, A. O'Shea-Greenfield, E.S. Deneris, C. Moll, U. Borgmeyer, M. Hollmann, and S. Heinemann Cloning of a novel glutamate receptor subunit, GluR5: expression in the nervous system during development Neuron 5 1990 583 595
15. D.J. Boullin, and R.A. O'Brien Abnormalities of 5-hydroxytryptamine uptake and binding by blood platelets from children with Down's syndrome J. Physiol. 146 1971 287 297
16. B.W. Brooksbank, and R. Balazs Superoxide dismutase, glutathione peroxidase and lipoperoxidation in Down's syndrome fetal brain Brain Res. 318 1 1984 37 44
17. B.W. Brooksbank, M. Martinez, and R. Balazs Composition and synthesis of polyunsaturated fatty acyl groups in the embryonic brain of the trisomy-16 mouse Int. J. Dev. Neurosci. 6 2 1988 193 201
18. K. Brousseau, and M.G. Brainerd A Study of the Physical and Mental Characteristics of Mongoloid Imbeciles 1928 Williams and Wilkins Baltimore
19. J. Busciglio, A. Pelsman, C. Wong, G. Pigino, M. Yuan, H. Mori, and B.A. Yankner Altered metabolism of the amyloid β precursor protein is associated with mitochondrial dysfunction in Down's syndrome Neuron 33 2002 677 688
20. A.M. Cárdenas, M.P. Rodríguez, M.P. Cortés, R.M. Alvarez, W. Wei, S.I. Rapoport, T. Shimahara, R. Caviedes, and P. Caviedes Intracellular calcium signals in immortal cell lines derived from the cerebral cortex of normal and trisomy 16 fetal mice, an animal model of human trisomy 21 (Down syndrome) Neuroreport 10 2 1999 363 369
21. A.M. Cárdenas, D.D. Allen, C. Arriagada, A. Olivares, L.B. Bennett, R. Caviedes, A. Dagnino-Subiabre, I.E. Mendoza, J. Segura-Aguilar, S.I. Rapoport, and P. Caviedes Establishment and characterization of immortalized neuronal cell lines derived from the spinal cord of normal and trisomy 16 fetal mice, an animal model of Down Syndrome J. Neurosci. Res. 68 2 2002 46 58
22. A.M. Cárdenas, C. Arriagada, D.D. Allen, R. Caviedes, J.F. Cortes, J. Martín, E. Couve, S.I. Rapoport, T. Shimahara, and P. Caviedes Neuronal cell lines from the hippocampus of the normal and trisomy 16 mouse fetus (a model for Down syndrome) exhibit neuronal markers, cholinergic function and functional neurotransmitter receptors Exp. Neurol. 177 1 2002 159 170
23. P. Caviedes, B. Ault, and S.I. Rapoport The role of altered sodium currents in the action potential abnormalities of cultured dorsal root ganglion neurons from trisomy 21 (Down syndrome) human fetuses Brain Res. 510 1990 229 236
24. P. Caviedes, J. Koistinaho, B. Ault, and S.I. Rapoport Effects of nerve growth factor on the electrical membrane properties of cultured dorsal root ganglia neurons from normal and trisomy 21 human fetuses Brain Res. 556 1991 285 291
25. P. Caviedes, E. Olivares, R. Caviedes, and E. Jaimovich Calcium fluxes, ion currents and dihydropyridine receptors in a newly established cell line from rat heart muscle J. Molec. Cell Cardiol. 25 1993 829 845
26. Caviedes, P., Fiedler, J., Caviedes, R., Epstein, C.J., Rapoport, S.I., 1995. Altered Calcium currents and cholinergic function in neurons of murine trisomy 16 fetuses, an animal model for human trisomy 21 (Down syndrome). In: 4th IBRO World Congress in Neuroscience, 9-14 July, Kyoto, Japan.
27. G.M. Cole, T.V. Huynh, and R.T. Saitoh Evidence for lysosomal processing of amyloid beta-protein precursor in cultured cells Neurochem. Res. 14 1989 933 939
28. G.L. Collingridge, S.L. Kehl, and H. McLeannan Excitatory amino acids in synaptic transmission in the Schaffer collateral-commissural pathway of the rat hippocampus J. Physiol. (Lond.) 334 1983 33 46
29. D.G. Cook, M.S. Forman, J.C. Sung, S. Leight, D.L. Kolson, T. Iwatsubo, V.M.-Y. Lee, and R.W. Doms Alzheimer's Abeta (1-42) is generated in the endoplasmic reticulum/intermediate compartment of NT2N cells Nat. Med. 3 1997 1021 1023
30. M.R. Costa, and W.A. Catterall Cyclic AMP-dependent phosphorylation of the alpha subunit of the sodium channel in synaptic nerve ending particles J. Biol. Chem. 259 1984 8210 8218
31. C.M. Coughlan, and K.C. Breen Factors influencing the processing and function of the amyloid b precursor protein-a potential therapeutic target in Alzheimer's disease? Pharmacol. Therapeutics 86 2000 111 144
32. D.R. Cox, L.B. Epstein, and C.J. Epstein Genes coding for sensitivity to interferon (IfRec) and soluble superoxide dismutase (SOD-1) are linked in mouse and man and map to mouse chromosome 16 Proc. Natl. Acad. Sci. USA 77 1980 2168 2172
33. M.T. Davisson, C. Schmidt, and E.C. Akeson Segmental trisomy murine chromosome 16: a new model system for studying Down syndrome Prog. Clin. Biol. Res. 360 1990 263 280
34. M.T. Davisson, C. Schmidt, R.H. Reeves, N.G. Irving, E.C. Akeson, B.S. Harris, and R.T. Bronson Segmental trisomy as a mouse model Down syndrome Prog. Clin. Biol. Res. 384 1993 117 133
35. F.G. De Felice, J.C. Houzel, J. Garcia-Abreu, P.R. Louzada Jr., R.C. Afonso, M.N. Meirelles, R. Lent, V.M. Neto, and S.T. Ferreira Inhibition of Alzheimer's disease beta-amyloid aggregation, neurotoxicity, and in vivo deposition by nitrophenols: implications for Alzheimer's therapy FASEB J. 15 2001 1297 1299
36. A.S. Dekaban Changes in brain weights during the span of human life: relation of brain weights to body heights and body weights Ann. Neurol. 4 1978 345 356
37. K.L. Double, M. Gerlach, M.B. Youdim, and P. Riederer Impaired iron homeostasis in Parkinson's disease J. Neural Transm. Suppl. 60 2000 37 58
38. C.J. Epstein The Neurobiology of Down Syndrome 1986 Raven Press New York pp. 1-15
39. C.J. Epstein The Consequence of Chromosomal Imbalance: Principles, Mechanisms, Models 1986 Cambridge University Press New York
40. C.J. Epstein, D.R. Cox, and L.B. Epstein Mouse trisomy 16: an animal model of human trisomy 21 (Down syndrome) Ann. NY Acad. Sci. 450 1985 157 168
41. F.S. Esch, P.S. Keim, E.C. Beattie, R.W. Blacher, A.R. Culwell, T. Oltersdorf, D. McClure, and P.J. Ward Cleavage of amyloid beta peptide during constitutive processing of its precursor Science 248 1990 1122 1124
42. J. Fiedler, S.I. Rapoport, C.J. Epstein, R. Caviedes, and P. Caviedes Altered cholinergic function in cultured neurons from the trisomy 16 mouse fetus, a model for Down Syndrome Brain Res. 658 1994 27 32
43. M.E. Figueiredo-Pereira, S. Efthimiopoulos, N. Tezapsidis, A. Buku, J. Ghiso, P. Mehta, and N.K. Robakis Distinct secretases, a cysteine protease and a serine protease, generate the C termini of amyloid beta-proteins Abeta1-40 and Abeta1-42, respectively J. Neurochem. 72 4 1999 1417 1422
44. C.E. Finch, and D.M. Cohen Aging, metabolism, and Alzheimer disease: review and hypotheses Exp. Neurol. 143 1997 82 101
45. S. Fisher, and M.L. Oster-Granite Developmental expression of amyloid precursor protein in normal and trisomy 16 mice Adv. Exp. Med. Biol. 265 1990 311 318
46. K. Frederiksen, S. Thorpe, S.J. Richards, J. Waters, S.B. Dunnet, and B.E.B. Sandberg Immortalized neural cells from trisomy 16 Mice as Models for Alzheimer's disease Annals NY Acad. Sci. 777 1996 415 420
47. W. Fu, H. Luo, S. Parthasarathy, and M.P. Mattson Catecholamines potentiate amyloid β-peptide neurotoxicity: involvement of oxidative stress, mitochondrial dysfunction, and perturbed calcium homeostasis Neurobiol. Dis. 5 1998 229 243
48. K. Fukuchi, K. Kamino, S.S. Deeb, A.C. Smith, T. Dang, and G.M. Martin Overexpression of amyloid precursor protein alters its normal processing and is associated with neurotoxicity Biochem. Biophys. Res. Commun. 182 1992 165 173
49. Z. Galdzicki, E. Coan, and S.I. Rapoport Cultured hippocampal neurons from trisomy 16 mouse, a model for Down's syndrome, have an abnormal action potential due to a reduced inward sodium current Brain Res. 604 1993 69 78
50. Z. Galdzicki, E.J. Coan, S.I. Rapoport, and J. Stoll Increased expression of voltage-activated calcium channels in cultured hippocampal neurons from mouse trisomy 16, a model for Down Syndrome Mol. Brain Res. 56 1998 200 206
51. Z. Galdzicki, R. Siarey, R. Pearce, J. Stoll, and S.I. Rapoport On the cause of mental retardation in Down syndrome: extrapolation from full and segmental trisomy 16 mouse models Brain Res. Rev. 35 2001 115 145
52. E.L. Gibbs, and F.A. Gibbs Rarity of 14- and 6-per-second positive spiking among mongoloids Neurology 14 1964 581 583
53. M.G. Giovannini, C. Scali, C. Prosperi, A. Bellucci, M.G. Vannucchi, S. Rosi, G. Pepeu, and F. Casamenti Beta-amyloid-induced inflammation and cholinergic hypofunction in the rat brain in vivo: involvement of the p38MAPK pathway Neurobiol. Dis. 11 2 2002 257 274
54. P. Gregor, B.F. O'Hara, X. Yang, and G.R. Uhl Expression and novel subunit isoforms of glutamate receptor genes GluR5 and GluR6 Neuroreport 4 12 1993 1343 1346
55. C. Haass, E.H. Koo, and A. Mellon Targeting of cell-surface beta-amyloid precursor protein to lysosomes: alternative processing into amyloid-bearing fragments Nature 357 1992 500 503
56. C. Haass, M.G. Schlossmacher, A.Y. Hung, C. Vigo-Pelfrey, A. Mellon, B.L. Ostaszewski, I. Lieberburg, E.H. Koo, D. Schenk, and D.B. Teplow Amyloid beta-peptide is produced by cultured cells during normal metabolism Nature 359 1992 322 327
57. T. Hartmann Intracellular biology of Alzheimer's disease amyloid beta peptide Eur. Arch. Psychiatry Clin. Neurosci. 249 1999 291 298
58. T. Hartmann, S.C. Bieger, B. Bruhl, J.P. Tienari, N. Ida, D. Allsop, G.W. Roberts, C.L. Masters, C.G. Dotti, K. Unsicker, and K. Beyreuther Distinct sites of intracellular production for Alzheimer's disease Abeta40/42 amyloid peptides Nat. Med. 3 1997 1016 1020
59. B.H. Harvey, C.B. Brink, S. Seedat, and D.J. Stein Defining the neuromolecular action of myo-inositol: application to obsessive-compulsive disorder Prog. Neuropsychopharmacol. Biol. Psychiatry 26 1 2002 21 32
60. M. Hattori, A. Fujiyama, T.D. Taylor, and H. Watanabe The DNA sequence of human chromosome 21 Nature 405 18 2000 311 319
61. J.V. Haxby Neuropsychological evaluation of adults with Down's syndrome: patterns of selective impairment in non-demented old adults J. Ment. Defic. Res. 33 1989 193 210
62. 2+-binding proteins in human neurodegenerative disorders TINS 15 7 1992 259 264
63. D.M. Holtzman, D. Santucci, J. Kilbridge, J. Chua-Couzens, D.J. Fontana, S.E. Daniels, R.M. Johnson, K. Chen, Y. Sun, E. Carlson, E. Alleva, C.J. Epstein, and W.C. Mobley Developmental abnormalities and age-related neurodegeneration in a mouse model of Down syndrome Proc. Natl. Acad. Sci. USA 93 1996 13333 13338
64. B. Horwitz, M.B. Schapiro, C.L. Grady, and S.I. Rapoport Cerebral metabolic pattern in young adult Down's syndrome subjects: altered intercorrelations between regional rates of glucose utilization J. Ment. Defic. Res. 34 1990 237 252
65. R. Hosoda, T.C. Saido, L. Otvos Jr., T. Arai, D.M. Mann, V.M. Lee, J.Q. Trojanowski, and T. Iwatsubo Quantification of modified amyloid beta peptides in Alzheimer disease and Down syndrome brains J. Neuropathol. Exp. Neurol. 57 11 1998 1089 1095
66. Z. Huang, W. Galdzicki, P. van Gelderen, A. Balbo, E.G. Chikhale, M.B. Schapiro, and S.I. Rapoport Brain myo-inositol level is elevated in Ts65Dn mouse and reduced after lithium treatment Neuroreport 11 2000 445 448
67. C.L. Hunter, O. Isacson, M. Melson, H. Bimonte-Nelson, H. Seo, L. Lin, K. Ford, M.S. Kindy, and A.-C. Granholm Regional alterations in amyloid precursor protein and nerve growth factor across age in a mouse model of Down's syndrome Neurosci. Res. 45 2003 437 445
68. K. Ishikawa, M. Tanaka, J.A. Black, and S.G. Waxman Changes in expression of voltage-gated potassium channels in dorsal root ganglion neurons following axotomy Muscle Nerve 22 1999 502 507
69. S. Kar, D. Seto, P. Gaudreau, and R. Quirion β-Amyloid-related peptides inhibit potassium-evoked acetylcholine release from rat hippocampal slices J. Neurosci. 16 1996 1034 1040
70. S. Kar, A.M. Issa, D. Seto, D.S. Auld, B. Collier, and R. Quirion Amyloid β-peptide inhibits high-affinity choline uptake and acetylcholine release in rat hippocampal slices J. Neurochem. 70 1998 2179 2187
71. M. Kawahara, Y. Kuroda, N. Arispe, and E. Rojas Alzheimer's β-amyloid, human islet amylin, and prion protein fragment evoke intracellular free calcium elevations by a common mechanism in a hypothalamic GnRH neuronal cell line J. Biol. Chem. 275 19 2000 14077 14083
72. J.-H. Kim, and D. Hammond Septal cell lines derived from the trisomy 16 mouse: generation, characterization, and response to NGF Brain Res. 671 1995 299 304
73. S. Kirischuk, F. Kirchhoff, V. Matyash, H. Kettenmann, and A. Verkhratsky Glutamate-triggered calcium signalling in mouse Bergmann glial cells in situ: role of inositol-1,4,5-trisphosphate-mediated intracellular calcium release Neuroscience 92 3 1999 1051 1059
74. C. Koch Computation and the single neuron [news] Nature 385 1997 207 210
75. E.H. Koo, S.L. Squazzo, D.J. Selkoe, and C.H. Koo Trafficking of cell-surface amyloid beta-protein precursor. 1. Secretion, endocytosis and recycling as detected by labeled monoclonal antibody J. Cell Sci. 109 1996 991 998
76. N. Kowall, A. McKee, B. Yanker, and M. Beal In vivo neurotoxicity of beta-amyloid [beta(1-40)] and the beta(25-35) fragment Neurobiol. Aging 13 1992 537 542
77. J.L. Liberona, P. Caviedes, S. Tascón, J.R. Giglio, S.V. Sampaio, J. Hidalgo, R. Caviedes, and E. Jaimovich Expression of ion channels during differentiation of a human skeletal muscle cell line J. Muscle Res. Cell Motil. 18 5 1997 586 598
78. R.R. Llinas The intrinsic electrophysiological properties of mammalian neurons: insights into central nervous system function Science 242 1988 1654 1664
79. P.R. Louzada Jr., A.C. Paula Lima, F.G. de Mello, and S.T. Ferreira Dual role of glutamatergic neurotransmission on amyloid β1-42 aggregation and neurotoxicity in embryonic avian retina Neurosci. Lett. 301 2001 59 63
80. A.R. Luria The Mentally Retarded Child 1963 Pergamon Press New York
81. M.M. Marcell, and V. Armstrong Auditory and visual sequential memory of Down syndrome and nonretarded children Am. J. Ment. Defic. 87 1982 86 95
82. M. Marin-Padilla Structural abnormalities of the cerebral cortex in human chromosomal aberrations: a Golgi study Brain Res. 44 1972 625 629
83. M. Marin-Padilla Pyramidal cell abnormalities in the motor cortex of a child with Down's syndrome: a Golgi study J. Comp. Neurol. 167 1976 63 81
84. C. Martínez-Cué, C. Baamonde, M.A. Lumbreras, I.F. Vallina, M. Dierssen, and J.A. Flórez A murine model for Down syndrome shows reduced responsiveness to pain Neuroreport 10 1999 1119 1122
85. E.R. Matarredona, M. Santiago, J. Cano, and A. Machado Involvement of iron in MPP+ toxicity in substantia nigra: protection by desferrioxamine Brain Res. 773 1997 76 81
86. E.E. McCoy, and J. England Excretion of 4-pyridoxic acid during deoxypyridoxine and pyridoxine administration to mongoloid and non-mongoloid subjects J. Nutr. 96 4 1968 525 528
87. I. Mendoza, C. Arriagada, A.M. Cárdenas, and P. Caviedes Overexpression of a metabolic product of the amyloid precursor protein in the CTb neuronal cell line Neurotoxicity Res. 4 2 2002 165 182
88. T. Mito, P.M. Pereyra, and L.E. Becker Neuropathology in patients with congenital heart disease and Down syndrome Pediatr. Pathol. 11 1991 867 877
89. K.P. Mohanakumar, I. Hanbauer, and C.C. Chiueh Neuroprotection by nitric oxide against hydroxyl radical-induced nigral neurotoxicity J. Chem. Neuroanat. 14 1998 195 205
90. K. Nieminen, B. Suárez-Isla, and S.I. Rapoport Electrical properties of cultured dorsal root ganglion neurons from normal and trisomy 21 human fetal tissue Brain Res. 474 1988 246 254
91. A. Oka, and S. Takashima The up-regulation of metabotropic glutamate receptor 5 (mGluR5) in Down's syndrome brains Acta Neuropathol. (Berl) 97 3 1999 275 278
92. C.B. Orozco, S.A. Smith, C.J. Epstein, and S.I. Rapoport Electrophysiological properties of cultured dorsal root ganglion and spinal cord neurons of normal and trisomy 16 fetal mice Brain Res. 429 1987 111 122
93. C.B. Orozco, C.J. Epstein, and S.I. Rapoport Voltage-activated sodium conductances in cultured normal and trisomy 16 dorsal root ganglion neurons from the fetal mouse Brain Res. 466 1988 265 274
94. M.L. Oster-Granite The neurobiologic consequences of autosomal trisomy in mice and men Brain Res. Bull. 16 1986 767 771
95. Paula Lima, A.C., Arriagada, C., Toro, R., Cárdenas, A.M., Caviedes, R., Ferreira, S.T., Caviedes, P., 2002. Nitrophenols reduce expression of intracellular β amyloid in the CTb neuronal cell line, derived from the trisomy 16 mouse. In: 32nd Annual Meeting, Society for Neuroscience, Orlando, FL, 2-7 November.
96. C. Pike, A. Walencewicz, C. Glabe, and C. Cotman In vitro aging of beta-amyloid protein causes peptide aggregation and neurotoxicity Brain Res. 563 1991 311 314
97. C. Pike, A. Walencewicz, C. Glabe, and C. Cotman Aggregation-related toxicity of synthetic beta-amyloid protein in hippocampal cultures Eur. J. Pharmacol. 207 1991 367 368
98. H.B. Pollard, N. Arispe, and E. Rojas Ion channel hypothesis for Alzheimer amyloid peptide neurotoxicity Cell Mol. Neurobiol. 15 5 1995 513 526
99. D.L. Price, D.R. Borchelt, L.C. Walker, and S.S. Sisodia Toxicity of synthetic A beta peptides and modeling of Alzheimer's disease Neurobiol. Aging 13 1992 623 625
100. M.B. Pulsifer The neuropsychology of mental retardation J. Int. Neuropsychol. Soc. 2 1996 159 176
101. D.P. Purpura Dendritic spine 'dysgenesis' and mental retardation Science 186 1974 1126 1128
102. S.I. Rapoport Brain evolution and Alzheimer's disease Rev. Neurol. (Paris) 144 1988 79 90
103. S.I. Rapoport, and Z. Galdzicki Electrical studies of cultured fetal human trisomy and mouse trisomy 21 neurons identify functional deficits that may lead to mental retardation in Down's syndrome Dev. Brain Dysfunct. 7 1994 265 288
104. N. Raz, I.J. Torres, S.D. Briggs, W.D. Spencer, A.E. Thornton, W.J. Loken, F.M. Gunning, J.D. McQuain, N.R. Driesen, and J.D. Acker Selective neuroanatomic abnormalities in Down's syndrome and their cognitive correlates: evidence from MRI morphometry Neurology 45 1995 356 366
105. R.H. Reeves, J.D. Gearhart, and J.W. Littlefield Genetic basis for a mouse model of Down syndrome Brain Res. Bull. 16 1986 803 814
106. G.P. Reynolds, and C.E. Warner Amino acid neurotransmitter deficits in adult Down's syndrome brain tissue Neurosci. Lett. 94 1988 224 227
107. S. Rossie, D. Gordon, and W.A. Catterall Identification of an intracellular domain of the sodium channel having multiple cAMP-dependent phosphorylation sites J. Biol. Chem. 262 1987 17530 17535
108. H. Sago, E.J. Carlson, D.J. Smith, J. Kilbridge, E.M. Rubin, W.C. Mobley, C.J. Epstein, and T.T. Huang Ts1Cje, a partial trisomy 16 mouse model for Down syndrome, exhibits learning and behavioral abnormalities Proc. Natl. Acad. Sci. USA 95 1998 6256 6261
109. M.B. Schapiro, H. Creasey, M. Schwartz, J.V. Haxby, B. White, A. Moore, and S.I. Rapoport Quantitative CT analysis of brain morphometry in adult Down's syndrome at different ages Neurology 37 1987 1424 1427
110. M.B. Schapiro, J.S. Luxenberg, J.A. Kaye, J.V. Haxby, R. Friedland, and S.I. Rapoport Serial quantitative CT analysis of brain morphometrics in adult Down's syndrome at different ages Neurology 39 1989 1349 1353
111. B. Schmidt-Sidor, K.E. Wisniewski, T.H. Shepard, and E.A. Sersen Brain growth in Down syndrome subjects 15 to 22 weeks of gestational age and birth to 60 months Clin. Neuropathol. 9 1990 181 190
112. 2+ signaling and mitochondrial deficiencies in hippocampal neurons of trisomy 16 mice: a model of Down's syndrome J. Neurosci. 18 1998 7216 7231
113. B.S. Scott, T.L. Petit, L.E. Becker, and B.A. Edwards Abnormal electric membrane properties of Down's syndrome DRG neurons in cell culture Brain Res. 254 1981 257 270
114. R. Scott Turner, N. Suzuki, A.S.C. Chyung, S.G. Younkin, and V.M.-Y. Lee Amyloids β 40 and β 42 are generated intracellularly in cultured human neurons and their secretion increases with maturation J. Biol. Chem. 271 1996 8966 8970
115. D.J. Selkoe, T. Yamazaki, M. Citron, M.B. Podlisny, E.H. Koo, B.D. Teplow, and C. Haass The role of APP processing and trafficking in the formation of amyloid β-protein Ann. NY Acad. Sci. 777 1996 57 64
116. H.U. Shetty, H.W. Holloway, L.D. Acevedo, and Z. Galdzicki Brain accumulation of myo-inositol in the trisomy 16 mouse, an animal model of Down's syndrome Biochem. J. 313 1996 31 33
117. M. Shoji, T.E. Golde, J. Ghiso, T.T. Cheung, S. Estus, L.M. Shaffer, X.D. Cai, D.M. McKay, R. Tintner, B. Frangione, and S.G. Younkin Production of the Alzheimer amyloid beta protein by normal proteolytic processing Science 258 1992 126 129
118. R.J. Siarey, J. Stoll, S.I. Rapoport, and Z. Galdzicki Altered long-term potentiation in the young and old Ts65Dn mouse, a model for Down Syndrome Neuropharmacology 36 1997 1549 1554
119. R.A. Simmons, D.L. Li, K.H. Hoo, M. Deverill, P.L. Ornstein, and S. Iyengar Kainate GluR5 receptor subtype mediates the nociceptive response to formalin in the rat Neuropharmacology 37 1998 25 36
120. S.S. Sisodia, and D.L. Price Role of the beta-amyloid protein in Alzheimer's disease FASEB J. 1995 366 370
121. D.M. Skovronsky, R.W. Doms, and V.M. Lee Detection of a novel intraneuronal pool of insoluble amyloid beta protein that accumulates with time in culture J. Cell Biol. 141 1998 1031 1039
122. R.M. Snider, M. McKinney, C. Forray, and E. Richelson Neurotransmitter receptors mediate cyclic GMP formation by involvement of arachidonic acid and lipoxygenase Proc. Natl. Acad. Sci. USA 81 1984 3905 3909
123. J. Stoll, and Z. Galdzicki Reduced expression of voltage-gated sodium channels in neurons cultured from trisomy 16 mouse hippocampus Int. J. Dev. Neurosci. 14 1996 749 760
124. S. Takashima, L.E. Becker, D.L. Armstrong, and F. Chan Abnormal neuronal development in the visual cortex of the human fetus and infant with Down's syndrome. A quantitative and qualitative Golgi study Brain Res. 225 1981 1 21
125. S. Tomita, Y. Kirino, and T. Suzuki Cleavage of Alzheimer's amyloid precursor protein (APP) by secretases occurs after O-glycosylation of APP in the protein secretory pathway. Identification of intracellular compartments in which APP cleavage occurs without using toxic agents that interfere with protein metabolism J. Biol. Chem. 273 13 1998 6277 6284
126. J.-B. Tu, and H. Zellweger Blood-serotonin deficiency in Down's syndrome Lancet 9 2 1965 715 716
127. K.E. Wisniewski, H.M. Wisniewski, and G.Y. Wen Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome Ann. Neurol. 17 1985 278 282
128. B.A. Yankner, L.A. Duffy, and D.A. Kirschner Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides Science 250 4978 1990 279 282
129. F.S. Yao, M.T. Caserta, and A.M. Wyrwicz In vitro 1H and 31P NMR spectroscopic evidence of multiple aberrant biochemical pathways in murine trisomy 16 brain development Int. J. Dev. Neurosci. 18 8 2000 833 841
130. C.M. Yates, J. Simpson, A. Gordon, A.F.J. Maloney, Y. Allison, I.M. Ritchie, and A. Urquart Catecholamines and cholinergic enzymes in pre-senile and senile Alzheimer-type dementia and Down's syndrome Brain Res. 280 1983 119 126
131. K. Yoshikawa, and K. Kuriyama Superoxide dismutase catalyzes activation of synaptosomal soluble guanylate cyclase from rat brain Biochem. Biophys. Res. Commun. 95 1980 529 534